Ependymoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

B7-H3-CAR T Cells for Pediatric CNS Tumors
Conditions: Central Nervous System Neoplasms; Atypical Teratoid/Rhabdoid Tumor; Diffuse Midline Glioma, H3 K27M-Mutant; Ependymoma; High Grade Glioma; Glioblastoma; Medulloblastoma Intervention: Drug: B7-H3-CAR T cells Sponsor: St. Jude Children's Research Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2023 Category: Research Source Type: clinical trials

B7-H3-CAR T Cells for Pediatric CNS Tumors
Conditions: Central Nervous System Neoplasms; Atypical Teratoid/Rhabdoid Tumor; Diffuse Midline Glioma, H3 K27M-Mutant; Ependymoma; High Grade Glioma; Glioblastoma; Medulloblastoma Intervention: Drug: B7-H3-CAR T cells Sponsor: St. Jude Children's Research Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2023 Category: Research Source Type: clinical trials

Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China
Conditions: Medulloblastoma; Central Nervous System Tumor, Pediatric; Ependymoma; Germ Cell Tumor; Glioma; Brain Tumor, Pediatric Intervention: Sponsor: Beijing Tiantan Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2023 Category: Research Source Type: clinical trials